- Home
- Applications
- libya
- disease patient
Show results for
Refine by
Disease Patient Product Applications Available In Libya
20 applications found
Heart failure is a disease with many stages. The onset may be rapid, or it may progress more gradually. But once heart failure starts; it usually becomes a lifelong disease that patients have to learn to live with. Living with heart failure can be easier once you understand the symptoms and can communicate with your health care providers to make sure you are receiving the right ...
ByImpulse Dynamics based in Marlton, NEW JERSEY (USA)
We deliver comfort and ...
BySonic Incytes Medical Corp. based in Vancouver, BRITISH COLUMBIA (CANADA)
Velacur can also be used to assess and manage other chronic liver diseases, resulting from viral infections, autoimmune disorders, metabolic diseases or excessive alcohol consumption. Like fatty liver disease, viral and autoimmune hepatitis are “silent” diseases of the liver. They show no symptoms until your liver is severely damaged, making it vital for early disease detection to limit progression and protect the health of your ...
BySonic Incytes Medical Corp. based in Vancouver, BRITISH COLUMBIA (CANADA)
Automated MRI analyses that may help inform earlier, more accurate viewsof CNS disease, such as Alzheimer’s, Parkinson’s and multiple sclerosis. For healthcare providers on the frontlines of diagnosing and treating central nervous system disease, and for your patients, Qynapse brings groundbreaking peace of mind by providing results you can trust through its flagship solution, QyScore. ...
ByQynapse based in Paris, FRANCE
Zymeworks’ mission is to develop transformative treatments that help patients return home to their loved ones, disease-free. In order to bring new treatments to patients, we conduct clinical trials to assess the safety and efficacy of our investigational medicines. ...
ByZymeworks Inc based in Vancouver, BRITISH COLUMBIA (CANADA)
Experience with two patients highlights the importance of understanding fluid status. A presentation by Critical Care luminary Professor Mervyn Singer of University College Hospital, London, contrasts two cases which underline the importance of having the most accurate haemodynamic diagnostics on ...
ByDeltex Medical Limited based in Chichester, UNITED KINGDOM
Shifting from Crisis Management to Health Maintenance. With an unparalleled approach, Vectorious’ V-LAP platform is emerging as the treatment choice for heart failure ...
ByVectorious based in Tel Aviv, ISRAEL
The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are endocrine/metabolic-related rare ...
ByRareStone Group based in Shanghai, CHINA
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular diseases. At present, more than 7,000 rare diseases have been found in humans, about 60% of which are neurological ...
ByRareStone Group based in Shanghai, CHINA
Using our platform, we are developing mRNA medicines for diverse uses and delivering them to patients across the globe. We are currently focusing on 4 medical areas - infectious diseases, immuno-oncology, rare diseases and autoimmune ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
CROs can differentiate their services to sponsors with the white-labeled Jeeva eClinical technology platform advantage. Maximize the probability of winning contracts with sponsors by differentiating your proposals with Jeeva eClinical cloud. Sponsors want to know how you can ensure faster patient recruitment and better retention compared to your peers. Jeeva can rapidly turnaround with a budget proposal and branded material for inclusion in your response to sponsor RFPs and support you throughout the ...
ByJeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA)
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Etelcalcetide is used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on hemodialysis.https://www.creative-peptides.com/product/etelcalcetide-item-10-101-140-34909.html ...
ByCreative Peptides based in New York, NEW YORK (USA)
Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. Stempeutics is seeking partnership for further clinical development and commercialization of Stempeucel® for Global ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
The term plasmapheresis encompass different techniques (filtration or adsorption on plasma), which remove not all but only specific elements contained in the plasma, and altogether allow to treat a large number of diseases. ...
ByInfomed SA based in Meinier, SWITZERLAND
Isolating edited-pluripotent stem cells with traditional sorting techniques can subject the cells to rough conditions in which gene expression, genomic stability and overall cell-health can become compromised. Microfluidic cell sorting with the WOLF, along with single cell deposition using the N1 single cell dispenser, eliminates the challenges that pluripotent stem cells face by sorting at gentle pressures without decompression shock and shear stress, and allow for efficient single cell deposition for high ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)
With Qynapse we all benefit from earlier and more accurate monitoring of patients. Patients, practitioners, researchers and you – the payer, all benefit from earlier, more accurate central nervous system disease diagnosis and monitoring of patients throughout the care continuum. Qynapse has the potential to help lower costs, drive up quality outcomes and improve patient satisfaction. Are you ready to transform neuroscience ...
ByQynapse based in Paris, FRANCE
As a diagnostic imaging tool, Breast MRI is used for a wide range of indications in breast disease management ...
ByAurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA)
Our flagship products, Virtue SAB and BackBeat CNT, have the potential to improve clinical outcomes and provide distinct commercial advantages within two of the largest and most well-established global medical device ...
ByOrchestra BioMed, Inc. based in New Hope, PENNSYLVANIA (USA)
Neurological impairments such as strokes, spinal cord injuries, traumatic brain injuries, cerebral palsy, multiple sclerosis, and Parkinson’s disease can significantly affect a patient’s mobility, and many patients affected with these conditions have a significant long-term mobility impairment. ...
ByTechno Concept based in Manosque, FRANCE